These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 21525407)

  • 1. TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.
    Revel FG; Moreau JL; Gainetdinov RR; Bradaia A; Sotnikova TD; Mory R; Durkin S; Zbinden KG; Norcross R; Meyer CA; Metzler V; Chaboz S; Ozmen L; Trube G; Pouzet B; Bettler B; Caron MG; Wettstein JG; Hoener MC
    Proc Natl Acad Sci U S A; 2011 May; 108(20):8485-90. PubMed ID: 21525407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine.
    Revel FG; Meyer CA; Bradaia A; Jeanneau K; Calcagno E; André CB; Haenggi M; Miss MT; Galley G; Norcross RD; Invernizzi RW; Wettstein JG; Moreau JL; Hoener MC
    Neuropsychopharmacology; 2012 Nov; 37(12):2580-92. PubMed ID: 22763617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.
    Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR
    Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics.
    Revel FG; Moreau JL; Gainetdinov RR; Ferragud A; Velázquez-Sánchez C; Sotnikova TD; Morairty SR; Harmeier A; Groebke Zbinden K; Norcross RD; Bradaia A; Kilduff TS; Biemans B; Pouzet B; Caron MG; Canales JJ; Wallace TL; Wettstein JG; Hoener MC
    Biol Psychiatry; 2012 Dec; 72(11):934-42. PubMed ID: 22705041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission.
    Alvarsson A; Zhang X; Stan TL; Schintu N; Kadkhodaei B; Millan MJ; Perlmann T; Svenningsson P
    J Neurosci; 2015 Oct; 35(41):14057-69. PubMed ID: 26468205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
    Xie Z; Westmoreland SV; Miller GM
    J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trace amine-associated receptor 1 as a monoaminergic modulator in brain.
    Xie Z; Miller GM
    Biochem Pharmacol; 2009 Nov; 78(9):1095-104. PubMed ID: 19482011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders.
    Wu R; Li JX
    CNS Drugs; 2021 Dec; 35(12):1239-1248. PubMed ID: 34766253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system.
    Bradaia A; Trube G; Stalder H; Norcross RD; Ozmen L; Wettstein JG; Pinard A; Buchy D; Gassmann M; Hoener MC; Bettler B
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20081-6. PubMed ID: 19892733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trace amine-associated receptor 1 modulates dopaminergic activity.
    Lindemann L; Meyer CA; Jeanneau K; Bradaia A; Ozmen L; Bluethmann H; Bettler B; Wettstein JG; Borroni E; Moreau JL; Hoener MC
    J Pharmacol Exp Ther; 2008 Mar; 324(3):948-56. PubMed ID: 18083911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Trace Amine-Associated Receptor 1 Stimulates an Antiapoptotic Signal Cascade via Extracellular Signal-Regulated Kinase 1/2.
    Shi X; Swanson TL; Miner NB; Eshleman AJ; Janowsky A
    Mol Pharmacol; 2019 Oct; 96(4):493-504. PubMed ID: 31409621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.
    Xie Z; Miller GM
    J Pharmacol Exp Ther; 2008 May; 325(2):617-28. PubMed ID: 18182557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective TAAR1 agonists induce conditioned taste aversion.
    Liu J; Wu R; Johnson B; Zhang Y; Zhu Q; Li JX
    Psychopharmacology (Berl); 2022 Oct; 239(10):3345-3353. PubMed ID: 36056214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.
    Panas HN; Lynch LJ; Vallender EJ; Xie Z; Chen GL; Lynn SK; Scanlan TS; Miller GM
    J Neurosci Res; 2010 Jul; 88(9):1962-9. PubMed ID: 20155805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers.
    Harmeier A; Obermueller S; Meyer CA; Revel FG; Buchy D; Chaboz S; Dernick G; Wettstein JG; Iglesias A; Rolink A; Bettler B; Hoener MC
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):2049-61. PubMed ID: 26372541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trace amine-associated receptor 1 agonists RO5263397 and RO5166017 attenuate quinpirole-induced yawning but not hypothermia in rats.
    Siemian JN; Zhang Y; Li JX
    Behav Pharmacol; 2017 Oct; 28(7):590-593. PubMed ID: 28704278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent manner.
    Yang SM; Ghoshal A; Hubbard JM; Gackière F; Teyssié R; Neale SA; Hopkins SC; Koblan KS; Bristow LJ; Dedic N
    Neuropsychopharmacology; 2024 Jun; 49(7):1091-1103. PubMed ID: 38110609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of trace amine-associated receptor 1 ameliorates PTSD-like symptoms.
    Peng L; Zhang J; Feng J; Ge J; Zou Y; Chen Y; Xu L; Zeng Y; Li JX; Liu J
    Biochem Pharmacol; 2024 Oct; 228():116236. PubMed ID: 38670437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro.
    Xie Z; Westmoreland SV; Bahn ME; Chen GL; Yang H; Vallender EJ; Yao WD; Madras BK; Miller GM
    J Pharmacol Exp Ther; 2007 Apr; 321(1):116-27. PubMed ID: 17234900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies.
    Dedic N; Dworak H; Zeni C; Rutigliano G; Howes OD
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.